|
Aug 10
|
GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
|
|
Aug 9
|
GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update
|
|
Jul 26
|
GeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023
|
|
Jul 24
|
GeoVax Announces Issuance of Ebola Vaccine Patent
|
|
Apr 26
|
GeoVax to Participate in the 4th Symposium on Infectious Diseases in the Immunocompromised Host
|
|
Apr 25
|
GeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023
|